![Dale G. Ando](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dale G. Ando
No open positions remaining
Profile
Dale G.
Ando worked as a Director-Clinical Gene Therapy at Chiron Corp.
from 1992 to 1997.
He then worked as Vice President-Clinical Research at Cell Genesys, Inc. from 1997 to 2004.
From 2004 to 2017, he worked as Chief Medical Officer & VP-Therapeutic Development at Sangamo Therapeutics, Inc. Additionally, he was a Member-Adenoviral Safety Committee at National Institutes of Health from 1997 to 2001.
Dr. Ando received his undergraduate degree from Stanford University and his doctorate from the University of Michigan.
Former positions of Dale G. Ando
| Companies | Position | End |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2017-02-02 |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Chief Tech/Sci/R&D Officer | 2003-12-31 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | 2000-12-31 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Chief Tech/Sci/R&D Officer | 1996-12-31 |
Training of Dale G. Ando
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
- Stock Market
- Insiders
- Dale G. Ando
